Page 790 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 790

CHaPtEr 56  Inflammatory Muscle Diseases                761



            TABLE 56.5  Clinical Features associated With Myositis-Specific autoantibodies
            autoantibodies         association         Characteristic Clinical Features
            Anti-Jo-1 and other    PM, DM, IMNM        Relatively acute onset of myositis, frequent interstitial lung disease, fever, Raynaud
             antisynthetases                            phenomenon, arthritis, mechanic’s hands, moderate response to therapy, persistent
                                                        disease. Patients sometimes meet criteria for SLE or RA, but muscle disease or lung
                                                        disease dominate the clinical picture and prognosis.
            Anti-SRP               IMNM                Very acute onset of myositis, often in autumn, severe weakness, no rash, palpitations,
                                                        females predominate, poor response to therapy
            Anti-Mi-2              DM                  Relatively acute onset of myositis, classic dermatomyositis rashes with V sign and shawl
                                                        sign, cuticular overgrowth, good response to therapy
            Anti-HMGCR             IMNM                Necrotizing myopathy, may be preceded by statin therapy, very high CK levels, minimal
                                                        muscle wasting
            Anti-MDA5              DM, Clinically      Clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease;
                                    amyopathic DM       characteristic skin findings include cutaneous ulcers and palmar papules
            Anti-TIF1-γ (p155/140)  DM                 Juvenile dermatomyositis and cancer-associated dermatomyositis
            Anti-SAE               DM                  Severe skin manifestations and dysphagia
            Anti-NXP-2             DM                  Associated with calcinosis and muscle contractures in children

           DM, dermatomyositis; IMNM, immune-mediated necrotizing myopathy; MDA5, melanoma differentiation–associated protein 5; NXP-2, nuclear matrix protein; PM, polymyositis; RA,
           rheumatoid arthritis; SAE, small ubiquitin-like modifier activating enzyme; SLE, systemic lupus erythematosus; SRP, signal recognition particle; TIF1-γ, transcription intermediary
           factor 1-γ.



           diseases (such as lupus, DM, and Sjögren syndrome) as well as
           in healthy subjects. 10                                Drugs and Toxins
             IBM must be distinguished from other chronic myopathies.   A large number of environmental agents have been associated
           These include acquired myopathies, such as those caused by   with myopathies. Drug-induced myopathy should be considered
           toxins,  and  genetically  determined  myopathies,  such  as  some   particularly in cases where no other cause has been identified.
           muscular dystrophies and the metabolic myopathies. There are   Sometimes the illness strikingly resembles the spontaneous disease.
           several important differences between IBM and these other   D-penicillamine, for example, can induce a variety of autoimmune
           myopathies. The distinction, however, is not as well defined as   phenomena, including an inflammatory myopathy that closely
           might be expected. Although some of the familial forms of IBM   resembles PM. A number of drugs can also produce myopathies
           have a distinctive clinical presentation, often early in life, there   that can be clinically confused with IIM but are histologically
           have been several families with the typical late onset and inflam-  distinct. This large group includes 3-hydroxy-3-methylglutaryl-
           matory picture of the presumed sporadic cases. Several genetic   coenzyme A (HMG-coA) reductase inhibitors, corticosteroids,
           loci have been identified in familial IBM, so it will be important   colchicine, and zidovudine (AZT).
           to assess any identified mutations in familial IBM–associated   In corticosteroid-induced myopathy, type II muscle fiber
           genes in sporadic cases. 11                            atrophy is prominent on muscle biopsy, and weakness improves
                                                                  when the dose is lowered. Colchicine can cause myopathy and
           ETIOLOGY                                               painful neuromyopathy. The CYP3A4 system metabolizes col-
                                                                  chicine, and taking another drug metabolized by the same pathway
           Immunological Clues to Origin                          can result in myopathy.  Muscle biopsy shows autophagic vacuoles
                                                                                   14
           The implications of myositis-specific autoantibodies that bind   that stain for acid phosphatase. Discontinuation of colchicine
           to and inhibit the function of native human enzymes involved   usually results in improvement. AZT produces a characteristic
           in the formation of new proteins are tantalizing and probably   mitochondrial myopathy. The myopathy associated with HIV
           significant. These autoantibodies  appear  to develop  before   infection can be distinguished from that caused by AZT by muscle
           symptomatic weakness or serum CK elevation, suggesting a close   biopsy, as characteristic mitochondrial abnormalities are found
           link to an initiating factor. Some of the clinical features, such as   in the latter. Amiodarone rarely causes proximal and distal muscle
           fever, arthritis, and lung disease, and the apparent seasonality   weakness, or the accompanying tremor or distal sensory loss.
           in onset of disease in patients with anti-SRP, are reminiscent of   Muscle biopsy reveals autophagic vacuoles with myeloid inclusions
           some viral infections. In patients with autoantibodies against   and debris. This is seen more commonly in patients with chronic
           one of the aminoacyl-tRNA synthetases, such as Jo-1 (histidyl-  kidney disease. The antimalarial drugs chloroquine and hydroxy-
           tRNA synthetase), the possible connection to a viral inciting   chloroquine produce a vacuolar myopathy, possibly by raising
           agent appeared compelling, as certain picornaviruses, which are   the intralysosomal pH so that the acid cathepsins that digest
           closely  related  to viruses  long  suspected  of causing  myositis,   waste products in the lysosome are inoperable, so waste products
           such as coxsackie viruses, can mimic tRNA in acting as a substrate   accumulate in vacuoles.
                                       12
           for an aminoacyl-tRNA synthetase.  Direct proof connecting
           picornaviruses to human myositis, however, has not been obtained.  Bacterial and Parasitic Diseases
             In individuals infected with HIV or human T-cell lymphotropic   Certain parasitic diseases can produce an illness by direct invasion
           virus (HTLV)-1, the development of IBM has been noted.   of muscle. Weakness, fever, and eosinophilia are usually present.
           However, it is not always the first manifestation in these cases.   Bacterial pyomyositis is uncommon in North America but occurs
           There is no evidence of viral replication within the muscles, but   more commonly in other parts of the world. It is attended by
           instead the chronic infection triggers an inflammatory response. 13  the signs of local infection and is often asymmetrical. A recent
   785   786   787   788   789   790   791   792   793   794   795